148 related articles for article (PubMed ID: 1493919)
41. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.
Wakabayashi G; Gelfand JA; Burke JF; Thompson RC; Dinarello CA
FASEB J; 1991 Mar; 5(3):338-43. PubMed ID: 1825816
[TBL] [Abstract][Full Text] [Related]
42. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
[TBL] [Abstract][Full Text] [Related]
43. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
[TBL] [Abstract][Full Text] [Related]
45. Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin.
Harada A; Sekido N; Kuno K; Akiyama M; Kasahara T; Nakanishi I; Mukaida N; Matsushima K
Int Immunol; 1993 Jun; 5(6):681-90. PubMed ID: 8347559
[TBL] [Abstract][Full Text] [Related]
46. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1.
Perretti M; Flower RJ
J Immunol; 1993 Feb; 150(3):992-9. PubMed ID: 8423349
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes.
Conti P; Panara MR; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
Agents Actions; 1992; Spec No():C93-5. PubMed ID: 1332453
[TBL] [Abstract][Full Text] [Related]
48. The interleukin-1 receptor antagonist and its delivery by gene transfer.
Evans CH; Robbins PD
Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease.
Thompson RC; Dripps DJ; Eisenberg SP
Int J Immunopharmacol; 1992 Apr; 14(3):475-80. PubMed ID: 1535616
[TBL] [Abstract][Full Text] [Related]
50. Effect of interleukin-1 receptor antagonist on concanavalin A response of peripheral blood mononuclear cells from newborn calves.
Yamanaka H; Katagiri Y; Domi M; Hagiwara K; Kirisawa R; Iwai H
J Vet Med Sci; 2001 Aug; 63(8):933-5. PubMed ID: 11558554
[TBL] [Abstract][Full Text] [Related]
51. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.
Ferretti M; Casini-Raggi V; Pizarro TT; Eisenberg SP; Nast CC; Cominelli F
J Clin Invest; 1994 Jul; 94(1):449-53. PubMed ID: 8040288
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-1 alpha and interleukin-1 beta stimulate adrenocorticotropin secretion in the rat through a similar hypothalamic receptor(s): effects of interleukin-1 receptor antagonist protein.
Matta SG; Linner KM; Sharp BM
Neuroendocrinology; 1993 Jan; 57(1):14-22. PubMed ID: 8386818
[TBL] [Abstract][Full Text] [Related]
53. Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever.
Opp MR; Krueger JM
Am J Physiol; 1991 Feb; 260(2 Pt 2):R453-7. PubMed ID: 1825458
[TBL] [Abstract][Full Text] [Related]
54. Development of a neutralizing monoclonal antibody against rabbit IL-1 receptor antagonist and utilization for ELISA and measurement of masked IL-1 activity in biological materials.
Matsukawa A; Furukawa S; Ohkawara S; Takagi K; Yoshinaga M
Immunol Invest; 1994 Mar; 23(2):129-42. PubMed ID: 8194853
[TBL] [Abstract][Full Text] [Related]
55. Increased fibrinogen synthesis in mice during the acute phase response: co-operative interaction of interleukin 1, interleukin 6, and interleukin 1 receptor antagonist.
Rokita H; Neta R; Sipe JD
Cytokine; 1993 Sep; 5(5):454-8. PubMed ID: 8142600
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate.
Conti P; Reale M; Panara MR; Fridas S; Placido FC; Barbacane RC
Calcif Tissue Int; 1993 Apr; 52(4):300-4. PubMed ID: 8385544
[TBL] [Abstract][Full Text] [Related]
57. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis.
Cominelli F; Nast CC; Duchini A; Lee M
Gastroenterology; 1992 Jul; 103(1):65-71. PubMed ID: 1535326
[TBL] [Abstract][Full Text] [Related]
58. The effects of interleukin-1 receptor antagonist on oxidant-induced arthritis in mice.
Miesel R; Ehrlich W; Wohlert H; Kurpisz M; Kröger H
Clin Exp Rheumatol; 1995; 13(5):595-601. PubMed ID: 8575137
[TBL] [Abstract][Full Text] [Related]
59. Sequential generation of cytokines during the initiative phase of inflammation, with reference to neutrophils.
Matsukawa A; Yoshinaga M
Inflamm Res; 1998 Oct; 47 Suppl 3():S137-44. PubMed ID: 9831316
[TBL] [Abstract][Full Text] [Related]
60. Role of interleukin-1 in the pathogenesis of experimental shigellosis.
Sansonetti PJ; Arondel J; Cavaillon JM; Huerre M
J Clin Invest; 1995 Aug; 96(2):884-92. PubMed ID: 7635983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
